Morales, Leah Mae R.

HRN: 22-95-67  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2023
DOXYCYCLINE 100MG (CAP)
04/26/2023
05/24/2023
PO
100mg
BID X 14 Days
Pelvic Inflammatory Disease
Waiting Final Action 
04/27/2023
CEFOTAXIME 500MG (VIAL)
04/27/2023
05/04/2023
IVTT
2g
Q12
Ectopic Pregnancy
Waiting Final Action 
05/05/2023
DOXYCYCLINE 100MG (CAP)
05/05/2023
05/10/2023
PO
100mg
BID
Pelvic Inflammatory Disease
Waiting Final Action 
05/05/2023
DOXYCYCLINE 100MG (CAP)
05/05/2023
05/12/2023
PO
100 Mg
BID
Pelvic Inflammatory Disease
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: